Free Trial
→ $169 Private Jet Trick Exposed (From International Living) (Ad)tc pixel Free CDIOW Stock Alerts

Cardio Diagnostics (CDIOW) Competitors

Cardio Diagnostics logo
$0.01 0.00 (-7.56%)
As of 10:45 AM Eastern
Compare

CDIOW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Cardio Diagnostics stock or one of its competitors? Cardio Diagnostics's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Cardio Diagnostics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Alvotech had 3 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for Cardio Diagnostics. Alvotech's average media sentiment score of 0.70 beat Cardio Diagnostics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Summary

Alvotech beats Cardio Diagnostics on 3 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Apollomics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.45KN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Apollomics Neutral

Summary

Apollomics beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does Cardio Diagnostics compare to Aravive?

Aravive (NASDAQ:ARAV) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Aravive Neutral
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Summary

Aravive beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to bioAffinity Technologies?

Cardio Diagnostics (NASDAQ:CDIOW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.78 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Neutral
bioAffinity Technologies Negative

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.45KN/AN/AN/AN/A
bioAffinity Technologies$5.85MN/AN/AN/AN/A

Summary

bioAffinity Technologies beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Cardio Diagnostics Neutral

Summary

Cardio Diagnostics beats BioVie on 1 of the 1 factors compared between the two stocks.

Get Cardio Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDIOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDIOW vs. The Competition

Export
MetricCardio DiagnosticsBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.76B$7.06B$13.32B
Dividend YieldN/A3.66%2.53%16.47%
P/E RatioN/A13.50274.9725.99
Price / SalesN/A1,180.99573.5785.51
Price / CashN/A118.3777.4152.81
Price / BookN/A16.0010.746.20
Net IncomeN/A-$22.65M$3.50B$382.01M
7 Day PerformanceN/A-4.32%-2.44%-1.42%
1 Month PerformanceN/A-13.49%-7.90%-5.62%
1 Year PerformanceN/A7.61%2.26%-1.74%

Cardio Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIOW
Cardio Diagnostics
N/A$0.01
-7.6%		N/A-52.8%$0.00$14.45KN/A17
ALVOW
Alvotech
N/A$0.38
flat		N/A-70.6%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
-6.0%		N/A-47.1%$0.00$8.50MN/A15
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.22
-15.0%		N/A+73.4%$0.00$5.85MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CDIOW) was last updated on 10/8/2026 by MarketBeat.com Staff.
From Our Partners
HOST Just Entered the AI Data Center Race in a BIG Way
Host Digital Inc (NYSE American: HOST) has completed its merger with Healthy Choice Wellness Corp as of Septem...
Trading Wire | Sponsoredtc pixel
Ominous New Day in America (Get Ready for it)
A market forecaster with a 55-year track record - including calls on 1970s double-digit inflation, the 1980s S...
Weiss Ratings | Sponsoredtc pixel
A Little Known Explorer Sits Near Major Gold Deposits
Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...
Wall Street Logic | Sponsoredtc pixel
$169 Private Jet Trick Exposed
For $169, a growing circle of travelers are booking private jets without the wait, the hassle, or the high pri...
International Living | Sponsoredtc pixel
Why The Biggest Names in AI Are Heading To The Arctic
Google contracted over 12 GW of energy last year and just announced a 15 billion dollar AI infrastructure inve...
The Tomorrow Investor | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel